Canton Strategic Holdings Inc CNTN

US Biotechnology

$1.86 ▼ -3.63% ($-0.07)

⬇️ Below Yest. Low 📅 Earnings This Week

Open $1.96

Prev Close $1.93

Day Range $1.80 – $1.96

52W Range $1.66 – $5.83

Market Cap $153.79M

Beta 1.53

EPS (TTM) $-1.57

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2022-01-12
Shares Out.	79,680,000
Website	cantonstrategic.com ↗
Phone	13026457400
Employees	12
Revenue	$1.5M
Gross Profit	$1.5M
Net Income	-$19.3M
Free Cash Flow	-$22.2M
Total Assets	$564.6M
Total Liabilities	$109.7M
Equity	$454.9M

About Canton Strategic Holdings Inc

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Canton Strategic Holdings Inc is a publicly traded company under the ticker symbol CNTN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.